Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00184
|
|||||
| Drug Name |
Potassium chloride
|
|||||
| Synonyms |
11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl]
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Hypokalemia [ICD11: 5C77] | Approved | [1] | |||
| Therapeutic Class |
Dietary supplement
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
ClK
|
|||||
| Canonical SMILES |
[Cl-].[K+]
|
|||||
| InChI |
InChI=1S/ClH.K/h1H;/q;+1/p-1
|
|||||
| InChIKey |
WCUXLLCKKVVCTQ-UHFFFAOYSA-M
|
|||||
| CAS Number |
CAS 7447-40-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 74.55 | Topological Polar Surface Area | 0 | ||
| Heavy Atom Count | 2 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 1 | |||
| PubChem CID | ||||||
| PubChem SID |
10318920
, 10534589
, 11528333
, 118218
, 15296892
, 24845368
, 24845466
, 24845837
, 24845849
, 24847015
, 24847722
, 24852090
, 24858895
, 24859155
, 24860713
, 24860847
, 24865635
, 24868525
, 24868598
, 24874855
, 24881076
, 24881793
, 24881794
, 24881795
, 24881796
, 24881797
, 24881798
, 24881799
, 24881800
, 24881801
, 24881802
, 24898470
, 24898546
, 24898635
, 24898905
, 24899026
, 24899027
, 24899042
, 29223954
, 46506038
, 48414359
, 48420072
, 48423984
, 53790740
, 5616990
, 56312095
, 56312742
, 56312789
, 7849122
, 8152993
|
|||||
| ChEBI ID |
ChEBI:32588
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | KCC1 | Transporter Info | Electroneutral potassium-chloride cotransporter 1 | Substrate | [2] | |
| KCC2 | Transporter Info | Electroneutral potassium-chloride cotransporter 2 | Substrate | [3] | ||
| KCC3 | Transporter Info | Electroneutral potassium-chloride cotransporter 3 | Substrate | [4] | ||
| NKCC1 | Transporter Info | Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1 | Substrate | [5] | ||
| NKCC2 | Transporter Info | Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2 | Substrate | [6] | ||
| OCTN2 | Transporter Info | Organic cation/carnitine transporter 2 | Substrate | [7] | ||
| References | ||||||
| 1 | Torsemide was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Human potassium chloride cotransporter 1 (SLC12A4) promoter is regulated by AP-2 and contains a functional downstream promoter element. Blood. 2004 Jun 1;103(11):4302-9. | |||||
| 3 | Tyrosine phosphorylation regulates the membrane trafficking of the potassium chloride co-transporter KCC2. Mol Cell Neurosci. 2010 Oct;45(2):173-9. | |||||
| 4 | Functional analysis of a potassium-chloride co-transporter 3 (SLC12A6) promoter polymorphism leading to an additional DNA methylation site. Neuropsychopharmacology. 2009 Jan;34(2):458-67. | |||||
| 5 | Expression of the sodium potassium chloride cotransporter (NKCC1) and sodium chloride cotransporter (NCC) and their effects on rat lens transparency. Mol Vis. 2010 May 4;16:800-12. | |||||
| 6 | Rare mutations in renal sodium and potassium transporter genes exhibit impaired transport function. Curr Opin Nephrol Hypertens. 2014 Jan;23(1):1-8. | |||||
| 7 | Mutations affecting GABAergic signaling in seizures and epilepsy. Pflugers Arch. 2010 Jul;460(2):505-23. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.